colchicine has been researched along with Diseases, Metabolic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, AI; Dedhia, N; Demidowich, AP; Yanovski, JA | 1 |
Concha, F; Oberpauer, B; Paris, E; Rios, JC; Valenzuela, P | 1 |
Aragón, A; Cerón, A; Sepúlveda, MA | 1 |
Girard, V; Gross, A | 1 |
Radi, I | 1 |
Barnes, CG | 1 |
Scott, JT | 1 |
1 review(s) available for colchicine and Diseases, Metabolic
Article | Year |
---|---|
[Gout].
Topics: Allopurinol; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Diet Therapy; Gout; Humans; Inosine Nucleotides; Joint Diseases; Metabolic Diseases; Orotic Acid; Purines; Urate Oxidase; Uric Acid; Uricosuric Agents | 1970 |
1 trial(s) available for colchicine and Diseases, Metabolic
Article | Year |
---|---|
[Effect of benzbromarone in uricemia and uricosuria].
Topics: Aspirin; Benzofurans; Chlorothiazide; Clinical Trials as Topic; Colchicine; Drug Combinations; Humans; Ketones; Kidney Diseases; Metabolic Diseases; Uric Acid | 1972 |
5 other study(ies) available for colchicine and Diseases, Metabolic
Article | Year |
---|---|
Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.
Topics: Adipose Tissue; Animals; Colchicine; Diabetes Mellitus, Type 2; Gout Suppressants; Humans; Immunity, Innate; Inflammasomes; Inflammation; Insulin Resistance; Macrophages; Metabolic Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Risk Factors | 2016 |
Overdose of colchicine in a three-year-old child.
Topics: Bone Marrow; Central Nervous System; Child, Preschool; Colchicine; Disseminated Intravascular Coagulation; Drug Overdose; Emergency Service, Hospital; Enzymes; Female; Humans; Intensive Care Units; Metabolic Diseases; Multiple Organ Failure; Neutropenia; Thrombocytopenia | 1995 |
Confusional syndrome as the presenting form of calcium pyrophosphate dihydrate deposition disease.
Topics: Aged; Calcium Pyrophosphate; Colchicine; Confusion; Female; Humans; Joint Diseases; Metabolic Diseases | 1992 |
The treatment of gout.
Topics: Acute Disease; Allopurinol; Colchicine; Diagnosis, Differential; Female; Gout; Humans; Indomethacin; Male; Metabolic Diseases; Phenylbutazone; Uric Acid | 1972 |
Management of gout.
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Metabolic Diseases; Phenylbutazone; Salicylates; Uric Acid; Uricosuric Agents | 1969 |